Cyclerion Therapeutics Inc — Quarterly Cash Flow (NASDAQ:CYCN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 8.9 M9.57 M9.85 M9.37 M10.41 M Total liabilities 700 K725 K1.07 M800 K877 K Total equity 8.2 M8.85 M8.78 M8.57 M9.54 M Total liabilities & shareholders' equities 8.9 M9.57 M9.85 M9.37 M10.41 M Total debt ————— Net debt —————

新闻

Cyclerion receives FDA feedback on depression treatment development

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Acrivon Therapeutics (NASDAQ:ACRV), AZZ (NYSE:AZZ)

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression - Slideshow (NASDAQ:CYCN) 2026-01-07

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

US Stocks Mixed; Nasdaq Gains Over 50 Points - Alumis (NASDAQ:ALMS), AngioDynamics (NASDAQ:ANGO)

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

Cyclerion Therapeutics股价因与Medsteer战略合作而飙升

Cyclerion partners with Medsteer to advance depression treatment platform

Cyclerion Therapeutics stock soars after strategic Medsteer collaboration

Cyclerion Therapeutics, Inc. (CYCN) Discusses on Pioneering a New Era in Neuropsychiatric Therapies (NASDAQ:CYCN) 2025-09-24

Cyclerion Therapeutics, Inc. (CYCN) Discusses on Pioneering a New Era in Neuropsychiatric